Page last updated: 2024-08-21

medroxyprogesterone and Carcinoma, Small Cell

medroxyprogesterone has been researched along with Carcinoma, Small Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, H; Wang, J; Zhang, P1
Kajanti, M; Mattson, K; Niiranen, A; Tammilehto, L1
Berman, ML; DiSaia, PJ; Mannel, RS; Rettenmaier, MA; Stratton, JA1

Trials

2 trial(s) available for medroxyprogesterone and Carcinoma, Small Cell

ArticleYear
[A clinical trial Furlutal in the prevention of anorexia, weight loss and myelosuppression due to chemotherapy].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1995, Volume: 17, Issue:4

    Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Medroxyprogesterone; Middle Aged; Weight Loss

1995
The clinical effect of medroxyprogesterone (MPA) in elderly patients with lung cancer.
    American journal of clinical oncology, 1990, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Medroxyprogesterone; Randomized Controlled Trials as Topic; Remission Induction; Survival Analysis

1990

Other Studies

1 other study(ies) available for medroxyprogesterone and Carcinoma, Small Cell

ArticleYear
Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay.
    Gynecologic oncology, 1989, Volume: 32, Issue:1

    Topics: Actuarial Analysis; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Subrenal Capsule Assay; Uterine Neoplasms

1989